- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05810272
Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults
The Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Many adults gradually lose muscle size, strength, and function after the age of 50. These losses are believed to occur faster with periods of reduced activity (e.g., lower step counts or physical movement when sick or injured) and can be difficult to regain by merely returning to a previously normal activity status. Such periods of reduced activity can also impair the body's ability to use the nutrients in the food consumed (e.g., proteins and carbohydrates), which increases the risk of frailty, type 2 diabetes, and ultimately a reduced quality of life. It is important to identify strategies to prevent these losses in muscle size, strength, and function especially during periods of reduced activity.
Recently, our laboratory has found that performing repeated bodyweight chair squats (repeated sit-to-stands with a calf raise) during a single day of reduced activity improves the muscle's ability to use carbohydrates and proteins, which may be a viable strategy to offset the negative effects of step reduction on muscle health.
In this study, the investigators will assess whether completing bodyweight chair squats at regular intervals (i.e., 'exercise snacks') reduces the negative effects of step reduction on carbohydrate and protein metabolism following a meal. The investigators will determine the impact of 'exercise snacks' (15 chair stands with calf raises every 30 min) compared to seated rest on protein and carbohydrate metabolism following three days of step reduction. The investigators will also assess how these responses compare to those seen following three days of normal (i.e., habitual) activity.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Daniel R Moore, PhD
- Phone Number: 4169464088
- Email: dr.moore@utoronto.ca
Study Contact Backup
- Name: Matthew J Lees, PhD
- Email: matthew.lees@utoronto.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5S 2C9
- Recruiting
- Goldring Center for High Performance Sport
-
Contact:
- Matthew J Lees, PhD
- Phone Number: 416-946-0400
- Email: matthew.lees@utoronto.ca
-
Contact:
- Hugo JW Fung, PhD (c)
- Email: hugojernwai.fung@utoronto.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy older (age: 60-80 y) adults
- BMI between normal to overweight (18.5-29.9 kg/m2)
Exclusion Criteria:
- Regular use of nonsteroidal anti-inflammatory drugs (with the exception of daily low-dose aspirin)
- Alcohol consumption during the study period
- Use of anticoagulants
- Use of a walker, cane, or assistive walking device
- Current or recently remised cancer
- Infectious or gastrointestinal disease
- Inability to comply with study protocol (e.g., >1,500 steps/day during Step-Reduction Phase)
- Regular tobacco use
- Self-reported illicit drug use (e.g. growth hormone, testosterone, etc.)
- Diagnosed chronic illness (e.g. type 2 diabetes, heart disease, thyroid disease)
- Hormonal Replacement Therapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Habitual Activity
Following three days of habitual activity, a metabolic trial will be completed wherein participants (10M/10F) will be assessed for their anabolic response to a protein-carbohydrate meal.
|
Participants will undergo a metabolic trial to assess for their anabolic response to a protein-carbohydrate meal.
|
|
Experimental: Step-Reduction
Participants will undergo three days of reduced physical activity (<1,500 steps/day) prior to a metabolic trial to establish their anabolic response to a protein-carbohydrate meal.
|
Participants will undergo a metabolic trial to assess for their anabolic response to a protein-carbohydrate meal.
Participants (n=10; 5F/5M) will be randomized to perform 15 sit-to-stands with calf raises every 30 minutes for the 4 hour duration between muscle biopsies
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Myofibrillar protein synthesis rates
Time Frame: 5 Hours
|
Myofibrillar protein synthesis rates assessed by incorporation of oral stable isotope tracer in both arms.
|
5 Hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Whole-body protein turnover
Time Frame: 5 Hours
|
Whole-body protein turnover assessed by oral stable isotope tracers in both arms.
|
5 Hours
|
|
Amino acid oxidation and net protein balance
Time Frame: 5 Hours
|
Amino acid oxidation and net protein balance assessed by oral tracers in both arms.
Net protein balance is derived from the difference between amino acid intake (known) and total amino acid oxidation over the 5h measurement period.
|
5 Hours
|
|
Postprandial insulin area under the curve (AUC) to mixed macronutrient breakfast
Time Frame: 5 Hours postprandial
|
The plasma insulin concentration measured by enzyme-linked immunosorbent assay (ELISA) area under the curve (AUC) will be quantified using the trapezoidal rule.
|
5 Hours postprandial
|
|
Postprandial glucose area under the curve (AUC) to mixed macronutrient breakfast
Time Frame: 5 hours postprandial
|
The plasma glucose concentration measured by hexokinase method area under the curve (AUC) will be quantified using the trapezoidal rule.
|
5 hours postprandial
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Hugo JW Fung, PhD, University of Toronto
- Principal Investigator: Daniel R Moore, PhD, University of Toronto
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ESPEN
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nervous System Diseases
-
Bracco Diagnostics, IncCompletedCentral Nervous System Neoplasms | Central Nervous System Disease
-
Delve Bio, Inc.Not yet recruiting
-
Bracco Diagnostics, IncCompletedCentral Nervous System Diseases | Central Nervous System NeoplasmsUnited States
-
Bracco Diagnostics, IncCompletedCentral Nervous System Diseases | Central Nervous System NeoplasmsUnited States
-
University of MichiganCompletedAutonomic Peripheral Nervous System DiseasesUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingCentral Nervous System TumorUnited States
-
Washington University School of MedicineRecruitingCentral Nervous SystemUnited States
-
The Hong Kong Polytechnic UniversityUnknownAutonomic Nervous System DisorderChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
Clinical Trials on Metabolic Trial
-
Pennington Biomedical Research CenterCompletedObesity | Metabolic SyndromeUnited States
-
PepsiCo Global R&DUniversity of Ontario Institute of TechnologyRecruitingThe Effect of Hydration Status on Substrate Oxidation at Rest and During Light and Moderate ExerciseHydration Status | Substrate Metabolism During ExerciseUnited States
-
Novo Nordisk A/SCompleted
-
Istituto Auxologico ItalianoRecruiting
-
University of MichiganAmerican Diabetes AssociationCompletedMetabolic SyndromeUnited States
-
China Medical University HospitalChina Medical University, Taiwan; National Science and Technology Council,...Completed
-
Poitiers University HospitalCompletedWeaning From Mechanical Ventilation | ExtubationFrance
-
Cliniques universitaires Saint-Luc- Université...Not yet recruiting
-
University of Texas Southwestern Medical CenterCompleted
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); American Society of Clinical OncologyRecruitingLeukemia | Acute LeukemiaUnited States